Reviva Pharmaceuticals prices $9 million public offering
PositiveFinancial Markets

Reviva Pharmaceuticals has successfully priced a $9 million public offering, a significant step for the company as it seeks to enhance its financial position and fund ongoing research and development. This move is crucial as it not only provides necessary capital but also signals investor confidence in Reviva's potential to innovate in the pharmaceutical sector.
— Curated by the World Pulse Now AI Editorial System